Evidence-Based Complementary and Alternative Medicine

History and Current Status of Evidence-Based Korean Medicine


Publishing date
23 Aug 2013
Status
Published
Submission deadline
05 Apr 2013

Lead Editor

1Laboratory of Clinical Biology and Pharmacogenomics and Center for Clinical Research and Genomics, Kyung Hee University, Seoul 130-701, Republic of Korea

2Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, 1901 East Road, Houston, TX 77054, USA

3School of Life Science and Institute of Biomedical Science, East China Normal University, Shanghai 200241, China

4Acupuncture and Meridian Science Research Center, Kyung Hee University, Seoul 130-701, Republic of Korea

5Institute for Innovative Cancer Research, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea

6Office of Health Services Research, National Evidence-Based Healthcare Collaborating Agency, Seoul 110-450, Republic of Korea


History and Current Status of Evidence-Based Korean Medicine

Description

The biomedical effects of natural products have been increasingly identified. Korean medicine originates from prehistoric times and shares its origin with Chinese medicine. However, Korean medicine, compared with the Chinese medicine, is not well known relatively. Though Korean medicine and Chinese medicine have a lot in common, Korean medicine has developed its own realm by developing unique approaches and research— "Four-Constitution (Sasang Constitutional) Medicine" as one of the diagnostic tools and Saam acupuncture as one of the treatments. In recent years, Korean medicine expanded its usages, thus, by integrating both traditional and modern approaches. Korean medicine covers many complementary and alternative approaches that are actively validated and developed. These efforts in the field of Korean medicine have been, and will be, an important contribution to the evidence-based complementary and alternative medicine.

In the light of these aims, we invite investigators to contribute original basic research articles, as well as comprehensive review articles, that reflect recent developments of Korean medicine as an evidence-based complementary and alternative approach. The contributing authors are encouraged to focus on Korean medicine as a system distinct from other approaches. A summarizing diagram is recommended to deliver the main results of their works. Potential topics include, but are not limited to:

  • New drugs discovery and development from natural products
  • Current clinical application
  • Latest technologies for clinical evaluation and measurement
  • Implication of Korean medicine in the treatment of refractory diseases, such as cancer, inflammatory diseases, diabetes, and neuronal disorders
  • Biological activities of extracts and isolated compounds from medicinal herbs developed

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ecam/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/ecam/korean/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 503867
  • - Editorial

History and Current Status of Evidence-Based Korean Medicine

Seong-Gyu Ko | Bharat B. Aggarwal | ... | Bo-Hyoung Jang
  • Special Issue
  • - Volume 2014
  • - Article ID 740515
  • - Review Article

Introduction to the History and Current Status of Evidence-Based Korean Medicine: A Unique Integrated System of Allopathic and Holistic Medicine

Chang Shik Yin | Seong-Gyu Ko
  • Special Issue
  • - Volume 2013
  • - Article ID 475386
  • - Research Article

Rubi Fructus (Rubus coreanus) Inhibits Differentiation to Adipocytes in 3T3-L1 Cells

Mi-Young Jeong | Hye-Lin Kim | ... | Seung-Heon Hong
  • Special Issue
  • - Volume 2013
  • - Article ID 453096
  • - Research Article

Relationships between Pathological Patterns and Quality of Life: Pathway Analysis

Shin-Woong Cho | Young-Jae Park | ... | Hwan-Sup Oh
  • Special Issue
  • - Volume 2013
  • - Article ID 975350
  • - Research Article

Trichosanthes kirilowii Ethanol Extract and Cucurbitacin D Inhibit Cell Growth and Induce Apoptosis through Inhibition of STAT3 Activity in Breast Cancer Cells

Soon Re Kim | Hye Sook Seo | ... | Seong-Gyu Ko
  • Special Issue
  • - Volume 2013
  • - Article ID 424730
  • - Research Article

Effects and Safety of Gyejibongnyeong-Hwan on Dysmenorrhea Caused by Blood Stagnation: A Randomized Controlled Trial

Jeong-Su Park | Sunju Park | ... | Seong-Gyu Ko
  • Special Issue
  • - Volume 2013
  • - Article ID 350964
  • - Research Article

Vasorelaxant Effect of Osterici Radix Ethanol Extract on Rat Aortic Rings

Kyungjin Lee | Geunyong Park | ... | Ho-Young Choi
  • Special Issue
  • - Volume 2013
  • - Article ID 310989
  • - Research Article

Paeonol, a Major Compound of Moutan Cortex, Attenuates Cisplatin-Induced Nephrotoxicity in Mice

Hyojung Lee | Gihyun Lee | ... | Hyunsu Bae
  • Special Issue
  • - Volume 2013
  • - Article ID 423741
  • - Research Article

Corni Fructus Containing Formulation Attenuates Weight Gain in Mice with Diet-Induced Obesity and Regulates Adipogenesis through AMPK

Hye-Lin Kim | Yong-Deok Jeon | ... | Jae-Young Um
  • Special Issue
  • - Volume 2013
  • - Article ID 671281
  • - Research Article

Ixeris dentata NAKAI Reduces Clinical Score and HIF-1 Expression in Experimental Colitis in Mice

Dae-Seung Kim | Jang-Ho Ko | ... | Seung-Heon Hong
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.